tetrahydrocortisone has been researched along with Hypertrophy, Left Ventricular in 1 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glorioso, N | 1 |
| Filigheddu, F | 1 |
| Parpaglia, PP | 1 |
| Soro, A | 1 |
| Troffa, C | 1 |
| Argiolas, G | 1 |
| Mulatero, P | 1 |
1 other study available for tetrahydrocortisone and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Blood Pressure; Cohort Studies; Cortodoxon | 2005 |